id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0493-0009,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Additional Criteria
and Procedures for Classifying Over-the-Counter Drugs as Generally
Recognized as Safe and Effective and Not Misbranded",Notice,30 Day Proposed Information Collection,2017-08-23T04:00:00Z,2017,8,2017-08-23T04:00:00Z,2017-09-23T03:59:59Z,2017-08-23T13:56:50Z,2017-17842,0,0,0900006482a9e2eb
FDA-2010-N-0493-0008,FDA,FDA-2010-N-0493,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Additional Criteria and Procedures for Classifying Overthe-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded",Notice,60 Day Proposed Information Collection,2017-05-30T04:00:00Z,2017,5,2017-05-30T04:00:00Z,2017-08-01T03:59:59Z,2017-05-30T15:32:04Z,2017-11008,0,0,0900006482665ebf